Skip to main content
VCbacked
Log inGet Started

Orbis Medicines

Frederiksberg, Denmark

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

$93.2M raised
Jan 2025
Series A
Health CareMedicalPharmaceuticalTherapeutics

Top Investors

New Enterprise AssociatesEli LillyCormorant Asset ManagementNovo HoldingsForbion Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Orbis Medicines

How much funding has Orbis Medicines raised?
Orbis Medicines has raised $93.2M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Who are Orbis Medicines's investors?
Orbis Medicines's investors include New Enterprise Associates, Eli Lilly, Cormorant Asset Management, Novo Holdings, Forbion Capital Partners.
Where is Orbis Medicines headquartered?
Orbis Medicines is headquartered in Frederiksberg, Denmark.
What does Orbis Medicines do?
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
What stage is Orbis Medicines at?
Orbis Medicines is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Orbis Medicines — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/orbis-medicines. Accessed June 3, 2026.
APA
VCBacked. (2025). Orbis Medicines — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/orbis-medicines
Wikipedia (cite web)
{{cite web |title=Orbis Medicines — Funding & Investors |url=https://www.vcbacked.co/company/orbis-medicines |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K